Despite many rumours about potential Bournemouth exits, some players are also being linked with a move to the south coast.

The Cherries currently have 11 players out on loan. VAVEL takes a look at how the key players are getting on at their ...

Follow live text commentary, score updates and match stats from Grenoble Foot 38 vs Lorient in the Ligue 2 ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

With the Cherries looking to push towards European football in the Premier League, the Daily Echo checks on what the club's loanees are ...

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

“Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price,” said Vishal Manchanda, senior vice-president, institutional research at Systematix Group. With the drop ...

Copyright 2025 The Associated Press. All Rights Reserved. Brazil’s Vinicius Junior celebrates after scoring his side’s second goal against Colombia during a FIFA ...

Brazil’s murky qualifying run for the 2026 World Cup got a late and big lift on Thursday, when Vinicius Junior’s goal in the ninth minute of stoppage time boosted the hosts to a 2-1 win over Colombia.

US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...